S. Robert Levine, MD, is founder and CEO of the Mary Tyler Moore Vision Initiative.

Ophthalmology Times Europe | Journals | Ophthalmology Times Europe connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye ...

PLEASE READ THE FOLLOWING TERMS AND CONDITIONS OF USE (THE “TERMS”) CAREFULLY BEFORE USING THIS WEB SITE (THE “SITE”) AND OTHER WEBSITES (THE “SITES”), INCLUDING ANY SUBDOMAINS THEREOF, OR ANY RELATED ...

SOL-1 results show intravitreal axitinib hydrogel delivered superior vision maintenance and anatomic outcomes through 52 weeks.

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Eichenbaum about the cell and gene therapy pipeline ahead, what sustains a career in ...

Danon disease has been misclassified as cone dystrophy, cone-rod dystrophy, or retinitis pigmentosa; distinguishing features include the absence of optic disc pallor, bone-spicule pigmentation, and a ...

Pineless is the Jerome and Joan Snyder Chair in Ophthalmology and director of the Residency Program at the University of California, Los Angeles Stein Eye Institute. She practices pediatric and ...

Two-year PRISM results show 4D-150 gene therapy sustains wet AMD vision while cutting anti-VEGF injections up to 87%, with ...

Ferrari is the co-inventor, with Prof Jorge Alió, of femtosecond laser-assisted annular keratopigmentation (FLAAK). In 2013, he performed the world's first eye colour change operation using ...

Talia R. Kaden, MD | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, Modern ...

Wilmer Eye Institute, Johns Hopkins University, ...